大动脉炎所致动脉狭窄腔内治疗的长期随访结果
肾动脉支架8年总体通畅率为93.7%(15/16),肾动脉干预1年和8年无再狭窄生存率分别为74%和57%(P=0.281)。
要点
- 大动脉炎所致动脉狭窄在疾病非活动期行腔内治疗,配合免疫抑制治疗可获得较好长期通畅。
- 33%的腔内干预发生再狭窄或闭塞,但经一次或多次再干预后92%的病变维持通畅。
- 肾动脉支架8年总体通畅率为93.7%(15/16)。
核心结论
- 在充分免疫抑制治疗下,腔内治疗配合一期或多期再干预可使92%的大动脉炎所致狭窄动脉病变获得长期通畅。
研究设计与样本
- 腔内治疗在疾病非活动期进行,患者术前接受免疫抑制药物预处理。
- 随访每3-6个月监测疾病活动度和药物治疗,每6个月行多普勒超声和磁共振血管造影。
- 腔内手术后平均随访83个月(范围12-144个月)。
- 采用Kaplan-Meier法和log-rank检验分析肾动脉手术的生存情况。
主要发现
- 对再狭窄病变行再干预后,45处(92%)病变获得一期辅助通畅。
- 最终评估时49处动脉病变中仅4处(8%)闭塞。
- 肾动脉支架随访8年总体通畅率为93.7%(15/16)。
- 肾动脉病变Kaplan-Meier分析中,肾动脉干预1年和8年无再狭窄生存率分别为74%和57%(P=0.281)。
临床怎么用
- 对大动脉炎所致动脉狭窄,应在疾病非活动期、免疫抑制治疗基础上行腔内治疗。
- 术后需定期监测疾病活动度并影像随访,再狭窄时可行一期或多期再干预。
局限性
- 为回顾性研究设计。
- 仅肾动脉病变数量足以行Kaplan-Meier生存分析,其他区域病变数量不足。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This retrospective study evaluated the long-term results of endovascular repair in the management of arterial stenosis caused by Takayasu's arteritis (TA). METHODS: Sixty-seven endovascular procedures (percutaneous transluminal balloon angioplasty or stenting) were performed for 49 arterial lesions in 35 patients. Endovascular treatment was performed when the disease was inactive. The patients were pretreated with immunosuppressive drugs and were followed every 3-6 months to monitor disease activity and medical treatment. Doppler ultrasonography and magnetic resonance angiography were performed every 6 months. Kaplan-Meier method with the log-rank test was used to analyze the survival of renal artery procedures because the number of lesions in other territories was not sufficient for statistical analysis. The mean follow-up duration after the endovascular procedure was 83 months (range: 12-144 months). RESULTS: Twenty-two (33%) endovascular interventions resulted in restenosis or occlusion. Reinterventions resulted in primary assisted patency in 45 (92%) lesions with restenosis. Only 4 (8%) of the 49 arterial lesions were occluded at the time of the final evaluation. The overall patency rate for the renal artery stents was 93.7% (15/16) after 8 years of follow-up. In the Kaplan-Meier survival analyses of the renal artery lesions, the 1- and 8-year restenosis-free survival rates of renal arterial interventions were 74% and 57%, respectively, (P = 0.281). CONCLUSIONS: In this study, endovascular treatment with adequate immunosuppressive medication resulted in long-term patency with one- or multi-stage reinterventions in 92% of stenotic arterial lesions caused by TA.
引用
- Gülcü A, Gezer NS, Akar S, et al. Long-Term Follow-Up of Endovascular Repair in the Management of Arterial Stenosis Caused by Takayasu's Arteritis. Ann Vasc Surg. 2017. PMID: 28323230. doi:10.1016/j.avsg.2016.10.066
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。